Evidence map›Paper›PMID 36136866›Full record

ArticleClinics and practice2022

Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers.

Zachary T Elliott, Zachary Goldberg, Ramez Philips, Jennifer M Johnson, Margaret T Kasner, William K Kelly, Sarah Osipowicz, Rachael Dampman, Joseph M Curry

Open access · goldAbstract read
In one paragraph

Article in Clinics and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zachary T ElliottDepartment of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA 19144, USA.ORCID 0000-0002-3454-3156
Zachary GoldbergDepartment of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Ramez PhilipsDepartment of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA 19144, USA.ORCID 0000-0003-3899-6678
Jennifer M JohnsonDepartment of Medical Oncology, Philadelphia, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Margaret T KasnerDepartment of Medical Oncology, Philadelphia, Thomas Jefferson University, Philadelphia, PA 19144, USA.
William K KellyDepartment of Medical Oncology, Philadelphia, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Sarah OsipowiczSidney Kimmel Cancer Center Protocol Review Committee, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Rachael DampmanSidney Kimmel Cancer Center Protocol Review Committee, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Joseph M CurryDepartment of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Thomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progress in the management of rare diseases, including rare cancers, is dependent upon clinical trials; however, as many as 32% of rare-disease trials go uncompleted or unpublished due to insufficient accrual. Monitoring practices may differ between institutions. We sought to survey the regulatory standards for various trial types among major U.S. cancer centers. A 10-question survey was designed using Qualtrics assessment software. The survey was sent via email to an internal server of member institutions of the Association of American Cancer Institutes (AACI). Of 103 AACI centers, 31% completed the survey (

Indexed as

accrual and monitoringclinical trialsrare diseases

Identifiers

PMID36136866
PMCPMC9498538
OpenAlexW4294142677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.